Every recall we track for Slate Run Pharmaceuticals — 3 in all — plus the complaints and injury reports the public filed about them.
Slate Run Pharmaceuticals recalls Eptifibatide Injection vials due to incorrect labeling for weight-adjusted dosing. The product states 'bolus' but should be 'infusion' for safe use. No remedy specified in official notice.
Slate Run Pharmaceuticals recalls 30mg Cinacalcet Hydrochloride Tablets due to nitrosamine impurity exceeding safe levels. This may pose health risks with long-term use. Consumers should contact the manufacturer for details.
Slate Run Pharmaceuticals recalls 60mg Cinac: Nitrosamine impurity exceeds safe limits. Rx-only tablets may pose health risks. Check NDC 70436-008-04 for affected lots.
